{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:40:37Z","timestamp":1782337237595,"version":"3.54.5"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.phrs.2026.108141","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:55:20Z","timestamp":1772096120000},"page":"108141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Proteolysis-targeting Chimeras induce ferroptosis in cancer: From Mechanism to clinical application"],"prefix":"10.1016","volume":"226","author":[{"given":"Na","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Yu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Dong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.phrs.2026.108141_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.phrs.2026.108141_bib2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.phrs.2026.108141_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108141_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"14","key":"10.1016\/j.phrs.2026.108141_bib5","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"Li","year":"2020","journal-title":"J. Hematol. & Oncol."},{"issue":"Pt 2","key":"10.1016\/j.phrs.2026.108141_bib7","article-title":"PROTAC-biomacromolecule conjugates for precise protein degradation in cancer therapy: A review","volume":"261","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"13","key":"10.1016\/j.phrs.2026.108141_bib8","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1039\/D1CS00762A","article-title":"Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation","volume":"51","author":"Chen","year":"2022","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2026.108141_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: the past is prologue","volume":"21","author":"B\u00e9k\u00e9s","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.phrs.2026.108141_bib10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1158\/1535-7163.MCT-23-0655","article-title":"Preclinical evaluation of bavdegalutamide (ARV-110), a novel PROteolysis targeting chimera androgen receptor degrader","volume":"24","author":"Snyder","year":"2025","journal-title":"Mol. Cancer Ther."},{"issue":"16","key":"10.1016\/j.phrs.2026.108141_bib11","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1158\/1078-0432.CCR-23-3465","article-title":"Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) Is Highly Efficacious as Monotherapy and in Combination with CDK4\/6 or PI3K\/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models","volume":"30","author":"Gough","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/bloodadvances.2022008121","article-title":"Orally bioavailable BTK PROTAC active against wild-type and C481 mutant BTKs in human lymphoma CDX mouse models","volume":"7","author":"Lim","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.phrs.2026.108141_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114533","article-title":"Recent advances in the development of EGFR degraders: PROTACs and LYTACs","volume":"239","author":"Hong","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2026.108141_bib14","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/acsmedchemlett.9b00385","article-title":"PROTAC degradation of IRAK4 for the treatment of neurodegenerative and cardiovascular diseases","volume":"10","author":"Kargbo","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.phrs.2026.108141_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cac2.12250","article-title":"Ferroptosis in cancer and cancer immunotherapy","volume":"42","author":"Zhao","year":"2022","journal-title":"Cancer communications"},{"issue":"8","key":"10.1016\/j.phrs.2026.108141_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein & Cell"},{"issue":"7784","key":"10.1016\/j.phrs.2026.108141_bib17","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"issue":"7860","key":"10.1016\/j.phrs.2026.108141_bib18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP Cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12964-023-01267-1","article-title":"Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death","volume":"21","author":"Li","year":"2023","journal-title":"Cell Communication Signaling CCS"},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41420-023-01753-y","article-title":"Ferritinophagy: research advance and clinical significance in cancers","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Death Discov."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108141_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/biology10030184","article-title":"Lipid metabolism and ferroptosis","volume":"10","author":"Lee","year":"2021","journal-title":"Biology"},{"issue":"24","key":"10.1016\/j.phrs.2026.108141_bib24","doi-asserted-by":"crossref","first-page":"12221","DOI":"10.1039\/D1FO00979F","article-title":"MUFA in metabolic syndrome and associated risk factors: is MUFA the opposite side of the PUFA coin?","volume":"12","author":"Sheashea","year":"2021","journal-title":"Food Funct."},{"issue":"6","key":"10.1016\/j.phrs.2026.108141_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.trecan.2023.03.003","article-title":"Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis","volume":"9","author":"Sen","year":"2023","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188394","article-title":"Cholesterol metabolism: new functions and therapeutic approaches in cancer","volume":"1874","author":"Xu","year":"2020","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"issue":"7545","key":"10.1016\/j.phrs.2026.108141_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108141_bib28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2018.05.074","article-title":"The tumor suppressor protein p53 and the ferroptosis network","volume":"133","author":"Kang","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2026.108141_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103066","article-title":"Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11\/GSH\/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation","volume":"70","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2026.108141_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102655","article-title":"miR-125b-5p in adipose derived stem cells exosome alleviates pulmonary microvascular endothelial cells ferroptosis via Keap1\/Nrf2\/GPX4 in sepsis lung injury","volume":"62","author":"Shen","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2026.108141_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111671","article-title":"Subchronic exposure to CeCl(3) promotes macrophage ferroptosis and atherosclerotic plaque formation by inhibiting the Keap1\/Nrf2\/GPX4 pathway","volume":"420","author":"Xie","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"49","key":"10.1016\/j.phrs.2026.108141_bib32","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"38","key":"10.1016\/j.phrs.2026.108141_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202402795","article-title":"MAPK signaling-mediated RFNG phosphorylation and nuclear translocation restrain oxaliplatin-induced apoptosis and ferroptosis","volume":"11","author":"Di","year":"2024","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12935-025-03681-6","article-title":"JAK\/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases","volume":"25","author":"Dai","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib35","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1038\/s41467-021-27452-9","article-title":"A targetable LIFR-NF-\u03baB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis","volume":"12","author":"Yao","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.phrs.2026.108141_bib36","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/15548627.2024.2319901","article-title":"International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis","volume":"20","author":"Chen","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2026.108141_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcancer.2019.03.002","article-title":"Ferroptosis is a type of autophagy-dependent cell death","volume":"66","author":"Zhou","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108141_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw2238","article-title":"Clockophagy is a novel selective autophagy process favoring ferroptosis","volume":"5","author":"Yang","year":"2019","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41419-020-03362-4","article-title":"Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.phrs.2026.108141_bib40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2020.02.005","article-title":"Autophagy-dependent ferroptosis: machinery and regulation","volume":"27","author":"Liu","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108141_bib41","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","article-title":"ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis","volume":"97","author":"Wang","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"Pt 3","key":"10.1016\/j.phrs.2026.108141_bib42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.semcancer.2022.03.009","article-title":"Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC","volume":"86","author":"Niu","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108141_bib43","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.ccell.2024.10.010","article-title":"Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance","volume":"42","author":"Lin","year":"2024","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.phrs.2026.108141_bib44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","article-title":"The mechanism of HMGB1 secretion and release","volume":"54","author":"Chen","year":"2022","journal-title":"Exp. & Mol. Med."},{"issue":"4","key":"10.1016\/j.phrs.2026.108141_bib45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phrs.2026.108141_bib46","doi-asserted-by":"crossref","unstructured":"CD36 Activity Causes Ferroptosis in Tumor-Infiltrating CD8(+) T Cells. Cancer discovery. 2021;11(5):Of24.","DOI":"10.1158\/2159-8290.CD-RW2021-039"},{"issue":"9","key":"10.1016\/j.phrs.2026.108141_bib47","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.immuni.2024.08.003","article-title":"PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8(+) T cell ferroptosis","volume":"57","author":"Ping","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib48","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","article-title":"Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41420-022-01297-7","article-title":"Recent progress in ferroptosis: inducers and inhibitors","volume":"8","author":"Du","year":"2022","journal-title":"Cell Death Discov."},{"issue":"51","key":"10.1016\/j.phrs.2026.108141_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904197","article-title":"Recent progress in ferroptosis inducers for cancer therapy","volume":"31","author":"Liang","year":"2019","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.phrs.2026.108141_bib51","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","article-title":"Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells","volume":"15","author":"Yang","year":"2008","journal-title":"Chem. & Biol."},{"issue":"7146","key":"10.1016\/j.phrs.2026.108141_bib52","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature05859","article-title":"RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels","volume":"447","author":"Yagoda","year":"2007","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.phrs.2026.108141_bib53","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","article-title":"Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"24","key":"10.1016\/j.phrs.2026.108141_bib54","doi-asserted-by":"crossref","first-page":"36021","DOI":"10.18632\/oncotarget.8651","article-title":"Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema","volume":"7","author":"Sehm","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib55","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41401-020-0439-x","article-title":"ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma","volume":"42","author":"Feng","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"issue":"22","key":"10.1016\/j.phrs.2026.108141_bib56","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.7150\/jca.58500","article-title":"FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.phrs.2026.108141_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155659","article-title":"Ferroptosis, a new pathogenetic mechanism in cardiometabolic diseases and cancer: is there a role for statin therapy?","volume":"146","author":"Sahebkar","year":"2023","journal-title":"Metab. Clin. Exp."},{"issue":"1-2","key":"10.1016\/j.phrs.2026.108141_bib58","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.phrs.2026.108141_bib59","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nchem.2778","article-title":"Salinomycin kills cancer stem cells by sequestering iron in lysosomes","volume":"9","author":"Mai","year":"2017","journal-title":"Nat. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2026.108141_bib60","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4143\/crt.2016.572","article-title":"Ferroptosis: a novel anti-tumor action for cisplatin","volume":"50","author":"Guo","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.phrs.2026.108141_bib61","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3389\/fphar.2018.01371","article-title":"RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer","volume":"9","author":"Sui","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108141_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117710","article-title":"Discovery of Artesunate (ARS) PROTACs as GPX4 protein degraders for the treatment of bladder cancer","volume":"293","author":"Yang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.phrs.2026.108141_bib63","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.tips.2024.05.006","article-title":"Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges","volume":"45","author":"Liu","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2026.108141_bib64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41551-025-01432-6","article-title":"Discovery of high-affinity ligands for prostatic acid phosphatase via DNA-encoded library screening enables targeted cancer therapy","volume":"10","author":"Georgiev","year":"2026","journal-title":"Nat. Biomed. Eng"},{"issue":"22","key":"10.1016\/j.phrs.2026.108141_bib65","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.7150\/thno.46985","article-title":"The peptide PROTAC modality: a novel strategy for targeted protein ubiquitination","volume":"10","author":"Jin","year":"2020","journal-title":"Theranostics"},{"issue":"7969","key":"10.1016\/j.phrs.2026.108141_bib66","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","article-title":"Phase separation of FSP1 promotes ferroptosis","volume":"619","author":"Nakamura","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108141_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107115","article-title":"A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression","volume":"202","author":"Hai","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"13","key":"10.1016\/j.phrs.2026.108141_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk1200","article-title":"Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases","volume":"10","author":"Huang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2026.108141_bib69","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.2147\/OTT.S248492","article-title":"Dihydroartemisinin inhibits the proliferation, colony formation and induces ferroptosis of lung cancer cells by inhibiting PRIM2\/SLC7A11 axis","volume":"13","author":"Yuan","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib70","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2016.07.033","article-title":"Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells","volume":"381","author":"Lin","year":"2016","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.phrs.2026.108141_bib71","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20193314","article-title":"Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition","volume":"40","author":"Yi","year":"2020","journal-title":"Biosci. Rep."},{"issue":"16","key":"10.1016\/j.phrs.2026.108141_bib72","doi-asserted-by":"crossref","first-page":"11335","DOI":"10.1021\/acs.jmedchem.3c00824","article-title":"Facilitated drug repurposing with artemisinin-derived PROTACs: unveiling PCLAF as a therapeutic target","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2026.108141_bib73","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.chembiol.2021.03.005","article-title":"The role of reversible and irreversible covalent chemistry in targeted protein degradation","volume":"28","author":"Kiely-Collins","year":"2021","journal-title":"Cell Chem. Biol."},{"issue":"18","key":"10.1016\/j.phrs.2026.108141_bib74","doi-asserted-by":"crossref","first-page":"16712","DOI":"10.1021\/acs.jmedchem.4c01518","article-title":"Heat shock protein 90 interactome-mediated proteolysis targeting chimera (HIM-PROTAC) DEgrading Glutathione Peroxidase 4 to Trigger Ferroptosis","volume":"67","author":"Dong","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2026.108141_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2023.149125","article-title":"A GPX4 non-enzymatic domain and MDM2 targeting peptide PROTAC for acute lymphoid leukemia therapy through ferroptosis induction","volume":"684","author":"Niu","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72491-9","article-title":"Bardoxolone conjugation enables targeted protein degradation of BRD4","volume":"10","author":"Tong","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108141_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116520","article-title":"Application and challenges of nitrogen heterocycles in PROTAC linker","volume":"273","author":"Li","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2026.108141_bib78","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acs.jcim.1c01036","article-title":"Impact of PROTAC linker plasticity on the solution conformations and dissociation of the ternary complex","volume":"62","author":"Weerakoon","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"19","key":"10.1016\/j.phrs.2026.108141_bib79","doi-asserted-by":"crossref","first-page":"13029","DOI":"10.1021\/acs.jmedchem.2c00877","article-title":"Linker-dependent folding rationalizes PROTAC cell permeability","volume":"65","author":"Poongavanam","year":"2022","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2026.108141_bib80","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1021\/acs.jmedchem.6b01781","article-title":"A \"Click Chemistry Platform\" for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation","volume":"61","author":"Wurz","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib81","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1038\/s41467-025-60107-7","article-title":"Linker-free PROTACs efficiently induce the degradation of oncoproteins","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"issue":"40","key":"10.1016\/j.phrs.2026.108141_bib82","doi-asserted-by":"crossref","first-page":"21860","DOI":"10.1021\/jacs.3c05948","article-title":"Selective protein of interest degradation through the split-and-mix liposome proteolysis targeting chimera approach","volume":"145","author":"Song","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.phrs.2026.108141_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115329","article-title":"A PARP1 PROTAC as a novel strategy against PARP inhibitor resistance via promotion of ferroptosis in p53-positive breast cancer","volume":"206","author":"Li","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"39","key":"10.1016\/j.phrs.2026.108141_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202206277","article-title":"Intracellular delivery of glutathione peroxidase degrader induces ferroptosis in vivo","volume":"61","author":"Luo","year":"2022","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.phrs.2026.108141_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117352","article-title":"Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4","volume":"90","author":"Cai","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2026.108141_bib86","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1021\/acs.jmedchem.2c01909","article-title":"ARE-PROTACs Enable Co-degradation of an Nrf2-MafG Heterodimer","volume":"66","author":"Ji","year":"2023","journal-title":"J. Med. Chem."},{"issue":"26","key":"10.1016\/j.phrs.2026.108141_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300871","article-title":"Exploiting cancer vulnerabilities by blocking of the DHODH and GPX4 pathways: a multifunctional Bodipy\/PROTAC nanoplatform for the efficient synergistic ferroptosis therapy","volume":"12","author":"Yao","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.phrs.2026.108141_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106461","article-title":"Ugi reaction-assisted assembly of covalent PROTACs against glutathione peroxidase 4","volume":"134","author":"Zhu","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2026.108141_bib89","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/acsmedchemlett.3c00571","article-title":"ZX703: a small-molecule degrader of GPX4 inducing ferroptosis in human cancer cells","volume":"15","author":"Hu","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2026.108141_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116110","article-title":"A potent GPX4 degrader to induce ferroptosis in HT1080 cells","volume":"265","author":"Song","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib91","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41419-025-07980-8","article-title":"Targeting DDX3X suppresses progression of KRAS-driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosis","volume":"16","author":"Dian","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2026.108141_bib92","article-title":"A pH-responsive PROTAC-based nanosystem triggers tumor-specific ferroptosis to construct in situ tumor vaccines","volume":"31","author":"Huang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.phrs.2026.108141_bib93","article-title":"PROTAC degraders of FSP1 act as potent GPX4 sensitizers to induce ferroptosis for hepatoma treatment","author":"Zhu","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.phrs.2026.108141_bib94","article-title":"HSP70 interactome-mediated proteolysis targeting chimera (HSP70-PROTAC) for ferroptosis-driven cancer treatment","author":"Dong","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2026.108141_bib95","article-title":"Targeted GPX4 Degradation Mediated by Hypoxia-Overcoming Nano-PDTACs for Synergistic Ferroptosis-Immunotherapy","author":"Ji","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"8096","key":"10.1016\/j.phrs.2026.108141_bib96","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41586-025-09710-8","article-title":"Targeting FSP1 triggers ferroptosis in lung cancer","volume":"649","author":"Wu","year":"2026","journal-title":"Nature"},{"issue":"8096","key":"10.1016\/j.phrs.2026.108141_bib97","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-025-09709-1","article-title":"Lymph node environment drives FSP1 targetability in metastasizing melanoma","volume":"649","author":"Palma","year":"2026","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.phrs.2026.108141_bib98","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1158\/0008-5472.CAN-23-1489","article-title":"ACSM1 and ACSM3 regulate fatty acid metabolism to support prostate cancer growth and constrain ferroptosis","volume":"84","author":"Shrestha","year":"2024","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.phrs.2026.108141_bib99","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","article-title":"Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones","volume":"186","author":"Liang","year":"2023","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.phrs.2026.108141_bib100","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41556-025-01722-w","article-title":"A ROS-mediated oxidation-O-GlcNAcylation cascade governs ferroptosis","volume":"27","author":"Zhang","year":"2025","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib101","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41556-023-01314-6","article-title":"Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition","volume":"26","author":"Cui","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib102","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13045-021-01223-x","article-title":"HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. & Oncol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108141_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167447","article-title":"Inhibition of DDR1 promotes ferroptosis and overcomes gefitinib resistance in non-small cell lung cancer","volume":"1870","author":"Zhang","year":"2024","journal-title":"Biochim. Et. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2026.108141_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103220","article-title":"A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma","volume":"73","author":"Miao","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2026.108141_bib105","article-title":"Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs","volume":"68","author":"Qi","year":"2023","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.phrs.2026.108141_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102408","article-title":"Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing","volume":"55","author":"Pontel","year":"2022","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.phrs.2026.108141_bib107","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.trecan.2021.04.005","article-title":"Targeting ferroptosis in pancreatic cancer: a double-edged sword","volume":"7","author":"Chen","year":"2021","journal-title":"Trends Cancer"},{"issue":"12","key":"10.1016\/j.phrs.2026.108141_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70211","article-title":"Proteolysis targeting chimera loaded extracellular vesicles for developing triple negative breast cancer treatment","volume":"14","author":"Erwin","year":"2025","journal-title":"J. Extracell. Vesicles"},{"issue":"11","key":"10.1016\/j.phrs.2026.108141_bib109","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1016\/j.apsb.2022.08.013","article-title":"Smart drug delivery systems for precise cancer therapy","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"17","key":"10.1016\/j.phrs.2026.108141_bib110","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1039\/D4NA00285G","article-title":"Smart delivery vehicles for cancer: categories, unique roles and therapeutic strategies","volume":"6","author":"Zeng","year":"2024","journal-title":"Nanoscale Adv."},{"issue":"1","key":"10.1016\/j.phrs.2026.108141_bib111","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13158","article-title":"Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1\u03b1\/SLC7A11 pathway","volume":"55","author":"Yuan","year":"2022","journal-title":"Cell Prolif."},{"key":"10.1016\/j.phrs.2026.108141_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113921","article-title":"Hypoxia-sensitive macrocycle inclusion complexes for targeted protein degradation","volume":"384","author":"Lin","year":"2025","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"16","key":"10.1016\/j.phrs.2026.108141_bib113","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207439","article-title":"Glutathione-scavenging nanoparticle-mediated PROTACs delivery for targeted protein degradation and amplified antitumor effects","volume":"10","author":"Liu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.phrs.2026.108141_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123101","article-title":"BRD4-targeted photodegradation nanoplatform for light activatable melanoma therapy","volume":"317","author":"Lu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2026.108141_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121110","article-title":"Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy","volume":"277","author":"Niu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2026.108141_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175913","article-title":"Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy","volume":"955","author":"Li","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108141_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2023.05.003","article-title":"Micronutrients\/miRs\/ATP networking in mitochondria: clinical intervention with ferroptosis, cuproptosis, and calcium burden","volume":"71","author":"Prasad Panda","year":"2023","journal-title":"Mitochondrion"},{"issue":"17","key":"10.1016\/j.phrs.2026.108141_bib118","doi-asserted-by":"crossref","first-page":"9815","DOI":"10.1021\/jacs.3c01852","article-title":"Small-molecule ferritin degrader as a pyroptosis inducer","volume":"145","author":"Chen","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.phrs.2026.108141_bib119","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1002\/1878-0261.13079","article-title":"Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A","volume":"15","author":"Gao","year":"2021","journal-title":"Mol. Oncol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108141_bib120","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","article-title":"Copper-dependent autophagic degradation of GPX4 drives ferroptosis","volume":"19","author":"Xue","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2026.108141_bib121","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7862430","article-title":"Hypoxia enhances glioma resistance to sulfasalazine-induced ferroptosis by upregulating SLC7A11 via PI3K\/AKT\/HIF-1\u03b1 Axis","volume":"2022","author":"Sun","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"D1","key":"10.1016\/j.phrs.2026.108141_bib122","doi-asserted-by":"crossref","first-page":"D1510","DOI":"10.1093\/nar\/gkae768","article-title":"PROTAC-DB 3.0: an updated database of PROTACs with extended pharmacokinetic parameters","volume":"53","author":"Ge","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"DI","key":"10.1016\/j.phrs.2026.108141_bib123","doi-asserted-by":"crossref","first-page":"D1510","DOI":"10.1093\/nar\/gkaf811","article-title":"MolGlueDB: an online database of molecular glues","volume":"54","author":"Wang","year":"2026","journal-title":"Nucleic Acids Res."},{"issue":"6693","key":"10.1016\/j.phrs.2026.108141_bib124","doi-asserted-by":"crossref","DOI":"10.1126\/science.adl2528","article-title":"Generalized biomolecular modeling and design with RoseTTAFold All-Atom","volume":"384","author":"Krishna","year":"2024","journal-title":"Science"},{"issue":"7976","key":"10.1016\/j.phrs.2026.108141_bib125","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","article-title":"De novo design of protein structure and function with RFdiffusion","volume":"620","author":"Watson","year":"2023","journal-title":"Nature"},{"issue":"6615","key":"10.1016\/j.phrs.2026.108141_bib126","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.add2187","article-title":"Robust deep learning-based protein sequence design using ProteinMPNN","volume":"378","author":"Dauparas","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.108141_bib127","article-title":"Predicting cellular responses to perturbation across diverse contexts with State","volume":"26","author":"Adduri","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.phrs.2026.108141_bib128","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/s41418-025-01528-1","article-title":"GPX4-AUTAC induces ferroptosis in breast cancer by promoting the selective autophagic degradation of GPX4 mediated by TRAF6-p62","volume":"32","author":"Gong","year":"2025","journal-title":"Cell death Differ."},{"issue":"18","key":"10.1016\/j.phrs.2026.108141_bib129","doi-asserted-by":"crossref","first-page":"12176","DOI":"10.1021\/acs.jmedchem.2c00855","article-title":"PDTAC: targeted photodegradation of GPX4 triggers ferroptosis and potent antitumor immunity","volume":"65","author":"Liu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2026.108141_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107115","article-title":"Design, synthesis, and biological evaluation of hydrophobic-tagged glutathione peroxidase 4 (GPX4) degraders","volume":"144","author":"Li","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.phrs.2026.108141_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116719","article-title":"Design, synthesis, and biological evaluation of RSL3-based GPX4 degraders with hydrophobic tags","volume":"277","author":"Ning","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"38","key":"10.1016\/j.phrs.2026.108141_bib132","doi-asserted-by":"crossref","first-page":"34672","DOI":"10.1021\/jacs.5c09843","article-title":"Enzyme-activated sugar-coated bifunctional degraders","volume":"147","author":"Zhu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"22","key":"10.1016\/j.phrs.2026.108141_bib133","article-title":"Enzyme-activated orthogonal proteolysis chimeras for tumor microenvironment-responsive immunomodulation","volume":"64","author":"Sun","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"6762","key":"10.1016\/j.phrs.2026.108141_bib134","doi-asserted-by":"crossref","DOI":"10.1126\/science.adx3595","article-title":"Load and lock: an emerging class of therapeutics that influence macromolecular dissociation","volume":"389","author":"Deshaies","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.phrs.2026.108141_bib135","article-title":"Ubiquitin receptor-induced proximity is sufficient for ubiquitin-independent targeted protein degradation via the 26S proteasome","volume":"2025","author":"Park","year":"2025","journal-title":"bioRxiv"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826000563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:41:19Z","timestamp":1773992479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826000563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":135,"alternative-id":["S1043661826000563"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108141","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteolysis-targeting Chimeras induce ferroptosis in cancer: From Mechanism to clinical application","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108141"}}